Table 4 Adverse events and grading.

From: Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

  

Grade 1

Grade 2

Grade 3

Grade 4

Grade 5

Infections

141

44

61

30

6

 Inpatient

97

     

 FUO

98

     

 Lung

23

     

 BSI

9

     

 Upper respiratory tract

4

     

 Skin

4

     

 Lower urinary tract

3

     

Allergy

48

     

 Urticaria

47

47

    

 Dress syndrome

1

  

1

  

Hemorrhage

3

     

 Skin

2

 

2

   

 GI tract

1

  

1

  

Thrombosis

3

     

 Limbs

3

 

3

   

Other

7

     

 Hepatic

5

 

1

3

1

 

 Cardiovascular

1

   

1

 

 GI tract

1

  

1

  
Back to article page